For: | Lu R, Zhang M, Liu ZH, Hao M, Tian Y, Li M, Wu FP, Wang WJ, Shi JJ, Zhang X, Jia XL, Jiang ZC, Li XM, Xu GH, Li YP, Dang SS. Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens. World J Gastroenterol 2024; 30(44): 4725-4737 [PMID: 39610775 DOI: 10.3748/wjg.v30.i44.4725] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i44/4725.htm |
Number | Citing Articles |
1 |
Li-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, Lin-Li Xu, Jing Li, Yan Cheng, Li-Jun Zheng, Cun-Wen Wu, Han-Xian Chen, Ze-Ren Chen, Jian-Qi Lian, Shi-Hong Wu, Li-Min Luo, Wei-Lu Zhang, Ye Zhang. Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study. Virology Journal 2025; 22(1) doi: 10.1186/s12985-025-02761-3
|
2 |
Jun Chen, Zebing Huang, Xueyao Yang, Yongwen Yang, Min Tan, Lihua Duan, Xuexuan Li, Shang Gao, Zhiliang Gao, Yan Huang. Predictors of Durable Hepatitis B Surface Antigen Loss After Pegylated Interferon–Based Therapy in Patients with Hepatitis B e Antigen–Negative Chronic Hepatitis B: A Multicenter Real-World Study. The Journal of Infectious Diseases 2025; doi: 10.1093/infdis/jiaf198
|